WEBSITE BSE:542920 NSE : SUMICHEM 28 Mar, 10:35
Market Cap ₹20131 Cr.
Stock P/E 40.1
P/B 8.8
Current Price ₹405.6
Book Value ₹ 46.3
Face Value 10
52W High ₹540.7
Dividend Yield 0.25%
52W Low ₹ 394.6
Sumitomo Chemical India Ltd engages within the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition merchandise in India and internationally. The agency operates through two segments, Agro Chemicals and Others. It gives crop protection merchandise, including insecticides, herbicides, fungicides, and miticides; plant nutrition and plant growth regulators; fumigants and rodenticides; methionine; and organic products. Sumitomo Chemical India Ltd also exports its merchandise. The company incorporated in 2000 and is based in Mumbai, India. Sumitomo Chemical India Ltd is a subsidiary of Sumitomo Chemical Company Ltd.
₹ | |
#(Fig in Cr.) | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 902 | 561 | 534 | 782 | 910 | 707 | 665 | 986 | 1122 | 754 |
Other Income | 6 | 5 | 5 | 5 | 8 | 6 | 7 | 5 | 11 | 13 |
Total Income | 908 | 566 | 539 | 787 | 918 | 713 | 672 | 990 | 1132 | 767 |
Total Expenditure | 683 | 483 | 463 | 632 | 696 | 581 | 556 | 798 | 844 | 633 |
Operating Profit | 225 | 83 | 76 | 155 | 223 | 133 | 116 | 192 | 289 | 134 |
Interest | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Depreciation | 11 | 11 | 13 | 11 | 11 | 11 | 11 | 11 | 15 | 11 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 212 | 71 | 61 | 142 | 210 | 120 | 104 | 180 | 272 | 121 |
Provision for Tax | 54 | 17 | 7 | 37 | 55 | 31 | 29 | 42 | 71 | 30 |
Profit After Tax | 158 | 54 | 54 | 106 | 154 | 89 | 75 | 138 | 201 | 90 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 158 | 54 | 54 | 106 | 154 | 89 | 75 | 138 | 201 | 90 |
Adjusted Earnings Per Share | 3.2 | 1.1 | 1.1 | 2.1 | 3.1 | 1.8 | 1.5 | 2.8 | 4 | 1.8 |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM |
---|---|---|---|---|---|---|
Net Sales | 1913 | 2228 | 2425 | 2645 | 3065 | 3527 |
Other Income | 30 | 8 | 11 | 19 | 27 | 36 |
Total Income | 1943 | 2236 | 2435 | 2663 | 3091 | 3561 |
Total Expenditure | 1693 | 1938 | 2090 | 2157 | 2463 | 2831 |
Operating Profit | 250 | 298 | 345 | 507 | 629 | 731 |
Interest | 5 | 4 | 7 | 7 | 8 | 4 |
Depreciation | 24 | 28 | 41 | 47 | 45 | 48 |
Exceptional Income / Expenses | 0 | -7 | -31 | 0 | 0 | 0 |
Profit Before Tax | 221 | 260 | 267 | 453 | 576 | 677 |
Provision for Tax | 76 | 94 | 62 | 108 | 152 | 172 |
Profit After Tax | 145 | 166 | 205 | 345 | 424 | 504 |
Adjustments | 0 | 0 | 0 | -0 | 0 | 0 |
Profit After Adjustments | 145 | 166 | 205 | 345 | 424 | 504 |
Adjusted Earnings Per Share | 0 | 0 | 4.1 | 6.9 | 8.5 | 10.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 16% | 11% | 0% | 0% |
Operating Profit CAGR | 24% | 28% | 0% | 0% |
PAT CAGR | 23% | 37% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -3% | 32% | NA% | NA% |
ROE Average | 24% | 23% | 22% | 22% |
ROCE Average | 34% | 30% | 28% | 28% |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
---|---|---|---|---|---|
Shareholder's Funds | 954 | 1048 | 1222 | 1541 | 1927 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 33 | 30 | 43 | 50 | 61 |
Total Current Liabilities | 672 | 781 | 840 | 1081 | 1021 |
Total Liabilities | 1658 | 1860 | 2105 | 2672 | 3010 |
Fixed Assets | 267 | 279 | 319 | 309 | 390 |
Other Non-Current Assets | 46 | 39 | 40 | 58 | 97 |
Total Current Assets | 1346 | 1542 | 1746 | 2304 | 2522 |
Total Assets | 1658 | 1860 | 2105 | 2672 | 3010 |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 59 | 74 | 50 | 93 | 188 |
Cash Flow from Operating Activities | 47 | 78 | 221 | 425 | 222 |
Cash Flow from Investing Activities | -40 | -35 | -118 | -283 | -290 |
Cash Flow from Financing Activities | 7 | -65 | -61 | -47 | -63 |
Net Cash Inflow / Outflow | 15 | -23 | 42 | 96 | -131 |
Closing Cash & Cash Equivalent | 74 | 50 | 93 | 188 | 57 |
# | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
---|---|---|---|---|---|
Earnings Per Share (Rs) | 0 | 0 | 4.1 | 6.92 | 8.49 |
CEPS(Rs) | 6.15 | 7.05 | 4.92 | 7.85 | 9.38 |
DPS(Rs) | 0 | 2.29 | 0.55 | 0.8 | 1 |
Book NAV/Share(Rs) | 0 | 0 | 24.48 | 30.88 | 38.61 |
Core EBITDA Margin(%) | 11.19 | 13.05 | 13.81 | 18.46 | 19.63 |
EBIT Margin(%) | 11.54 | 11.83 | 11.28 | 17.4 | 19.05 |
Pre Tax Margin(%) | 11.26 | 11.66 | 10.99 | 17.14 | 18.79 |
PAT Margin (%) | 7.4 | 7.44 | 8.44 | 13.06 | 13.82 |
Cash Profit Margin (%) | 8.61 | 8.69 | 10.13 | 14.82 | 15.28 |
ROA(%) | 8.75 | 9.42 | 10.32 | 14.46 | 14.91 |
ROE(%) | 19.89 | 21.35 | 20.01 | 25 | 24.42 |
ROCE(%) | 23.48 | 25.94 | 23.9 | 33.31 | 33.66 |
Receivable days | 102.66 | 100.14 | 114.46 | 117.16 | 100.72 |
Inventory Days | 113.36 | 105.63 | 95.48 | 92.62 | 100.77 |
Payable days | 175.76 | 142.73 | 120.74 | 132.94 | 117.2 |
PER(x) | 0 | 0 | 44.73 | 42.04 | 52.98 |
Price/Book(x) | 0 | 0 | 7.49 | 9.42 | 11.64 |
Dividend Yield(%) | 0 | 0 | 0.3 | 0.28 | 0.22 |
EV/Net Sales(x) | 0.11 | 0.11 | 3.74 | 5.4 | 7.3 |
EV/Core EBITDA(x) | 0.84 | 0.81 | 26.24 | 28.16 | 35.58 |
Net Sales Growth(%) | 0 | 16.5 | 8.81 | 9.08 | 15.87 |
EBIT Growth(%) | 0 | 16.44 | 3.81 | 68.21 | 26.83 |
PAT Growth(%) | 0 | 14.25 | 23.46 | 68.74 | 22.62 |
EPS Growth(%) | 0 | 0 | 0 | 68.69 | 22.66 |
Debt/Equity(x) | 0.01 | 0.02 | 0 | 0 | 0 |
Current Ratio(x) | 2 | 1.97 | 2.08 | 2.13 | 2.47 |
Quick Ratio(x) | 1.1 | 1.1 | 1.38 | 1.43 | 1.55 |
Interest Cover(x) | 42.11 | 70.93 | 38.61 | 66.45 | 73.17 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 |
# | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
FII | 0.77 | 1.15 | 1.12 | 1.22 | 1.32 | 1.36 | 1.69 | 1.9 | 2.05 | 2.44 |
DII | 5.27 | 6.61 | 6.28 | 6.57 | 6.13 | 6.17 | 6.35 | 6.7 | 6.4 | 5.52 |
Public | 18.96 | 17.24 | 17.59 | 17.21 | 17.55 | 17.47 | 16.95 | 16.4 | 16.54 | 17.03 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 | 37.44 |
FII | 0.38 | 0.57 | 0.56 | 0.61 | 0.66 | 0.68 | 0.85 | 0.95 | 1.02 | 1.22 |
DII | 2.63 | 3.3 | 3.14 | 3.28 | 3.06 | 3.08 | 3.17 | 3.34 | 3.2 | 2.76 |
Public | 9.46 | 8.6 | 8.78 | 8.59 | 8.76 | 8.72 | 8.46 | 8.19 | 8.26 | 8.5 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 49.91 | 49.91 | 49.91 | 49.91 | 49.91 | 49.91 | 49.91 | 49.91 | 49.91 | 49.91 |
See More Unlisted Share Articles
You May Also Know About